Clinical and laboratory features of seven patients with acute myeloid leukemia (AML)-M2/M3 and elevated myeloblasts and abnormal promyelocytes

BACKGROUND: There is limited information on a special subtype of Acute myeloid leukemia (AML) characterized by >20% myeloblasts and >20% abnormal promyelocytes in bone marrow and peripheral blood. OBJECTIVE: The objective of the present investigation was to explore the clinical and laboratory...

Descripción completa

Detalles Bibliográficos
Autores principales: He, GanLin, Wang, ChunYan, Li, QingEn, Tan, Huo, Chen, FuXiong, Huang, ZhenQian, Yu, BaoDan, Zheng, LiXia, Zheng, RunHui, Liu, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325959/
https://www.ncbi.nlm.nih.gov/pubmed/25678855
http://dx.doi.org/10.1186/s12935-014-0111-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325959/
https://www.ncbi.nlm.nih.gov/pubmed/25678855
http://dx.doi.org/10.1186/s12935-014-0111-y

Ejemplares similares